Phentermine and topiramate 11.25 mg/1 (Phentermine and topiramate CAPSULE, EXTENDED RELEASE) 11.25 mg/1

Phentermine and topiramate 11.25 mg/1 extended-release capsules are a combination medication used for weight management. This prescription-only treatment is designed to support weight loss efforts in conjunction with a reduced-calorie diet and increased physical activity.

Strength

11.25 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-2299-56)

Manufacturer / TM Owner

Teva Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Phentermine and topiramate 11.25 mg/1 is primarily used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition. This medication is intended for individuals with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one obesity-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia. The combination of phentermine, an appetite suppressant, and topiramate, an anticonvulsant, works to reduce appetite and promote weight loss.

Side Effects

Common effects of phentermine and topiramate 11.25 mg/1 may include decreased appetite, increased energy levels, and weight loss. Some users may experience side effects such as dry mouth, constipation, dizziness, or changes in taste. It is important to note that individual responses to the medication can vary, and not everyone will experience the same effects.

Precautions & Warnings

Phentermine and topiramate 11.25 mg/1 should be used with caution and under the supervision of a healthcare provider. It is important to follow the prescribed dosage and not to exceed the recommended amount. This medication should not be used during pregnancy or while breastfeeding. Individuals with a history of heart disease, hyperthyroidism, glaucoma, or those taking certain medications should consult their healthcare provider before starting this treatment.

Avoid Interactions

Phentermine and topiramate 11.25 mg/1 may interact with other medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and other appetite suppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided while taking this medication, as it may increase the risk of side effects.

Frequently Asked Questions

Phentermine and topiramate 11.25 mg/1 is used for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition.

Phentermine and topiramate 11.25 mg/1 should be taken orally, typically once daily in the morning, with or without food, as directed by a healthcare provider.

Common side effects may include dry mouth, constipation, dizziness, and changes in taste. Individual responses can vary.

Phentermine and topiramate 11.25 mg/1 should not be used during pregnancy. Consult a healthcare provider for personalized advice.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.